Muckle-Wells Syndrome - 14 Studies Found
Completed |
: Interleukin-1 Trap to Treat Autoinflammatory Diseases :
|
Completed |
: The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada : Cryopyrin Associated Periodic Syndrome : 2010-03-25 : Drug: canakinumab (company code: ACZ885D) |
Completed |
: Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients :
|
Terminated |
: HL2351 CAPS Phase II Study : Cryopyrin‑Associated Periodic Syndromes (CAPS) : 2016-05-10 : Drug: HL2351 The dose will be adjusted based on disease activities |